(1)
Gottlieb, A. B.; Elewski, B. E.; Okun, M. M.; Bagel, J.; Poulin, Y.; Gu, Y.; Geng, Z.; Williams, D. A.; Valdecantos, W. C. Adalimumab for Nail Psoriasis: Efficacy and Safety from the Open-Label Extension of a Phase-3, Randomized, Placebo-Controlled Trial. J of Skin 2017, 1, s97.